Completed OBSERVATIONAL NCT02290899

Modulation of Behavioral Inhibition in Attention Deficit Hyperactivity Disorder

Sponsor: Bradley Hospital

Conditions ADHD

Updated 8 times since 2017 Last updated: Aug 8, 2017 Started: Jun 30, 2014 Primary completion: Aug 7, 2017 Completion: Aug 7, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates ADHD and is currently completed. Bradley Hospital leads this study, which shows 8 recorded versions since 2014 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 3 earlier versions

Aug 2017 — Apr 2018 [monthly]

Completed NA

Status: Recruiting → Completed
May 2017 — Aug 2017 [monthly]

Recruiting NA
Jan 2017 — May 2017 [monthly]

Recruiting NA

First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bradley Hospital
Nancy Lurie Marks Family Foundation
Rhode Island Hospital

Data source: Rhode Island Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• East Providence, United States